Study of a cyclopamine glucuronide prodrug for the selective chemotherapy of glioblastoma

European Journal of Medicinal Chemistry

Volumn 45, Issue 4, 2010, Pages 1678-1682

  Hamon, Florian ^a   Renoux, Brigitte ^a   Chadéneau, Corinne ^a   Muller, Jean Marc ^a   Papot, Sébastien ^a  

^a UNIVERSITÉ DE POITIERS   (France)

Author keywords

Chemotherapy; Cyclopamine; Glioblastoma; Glucuronide; Prodrug

Indexed keywords

CYCLOPAMINE; GLUCURONIDE; PRODRUG;

ARTICLE; BIOLOGICAL ACTIVITY; CANCER CHEMOTHERAPY; CELL GROWTH; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DRUG ACTIVITY; DRUG RELEASE; DRUG STABILITY; DRUG SYNTHESIS; GLIOBLASTOMA; HUMAN; HUMAN CELL; HYDROLYSIS;

ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; CELL LINE, TUMOR; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; GLIOBLASTOMA; GLUCURONIDES; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; PRODRUGS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; VERATRUM ALKALOIDS;

EID: 77349107604     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2009.12.067     Document Type: Article

References (31)

1. Demuth T., and Berens M.E. J. Neurooncol. 70 (2004) 217-228
2. Ohgaki H., and Kleihues P. J. Neuropathol. Exp. Neurol. 64 (2005) 479-489
3. Vescovi A.L., Galli R., and Reynolds B.A. Nat. Rev. Cancer 6 (2006) 425-436
4. Quigley M.R., Post C., and Ehrlich G. Neurosurg. Rev. 30 (2007) 16-20
5. Mehler M.F. Results Probl. Cell Differ. 39 (2002) 27-52
6. Briscoe J., and Therond P. Dev. Cell 8 (2005) 143-151
7. Muller J.-M., Chevrier L., Cochaud S., Meunier A.-C., and Chadeneau C. Drug Discov. Today Dis. Mech. 4 (2007) 285-291
8. Hutchin M.E., Kariapper M.S., Grachtchouk M., Wang A., Wei L., Cummings D., Liu J., Michael L.E., Glick A., and Dlugosz A.A. Genes Dev. 19 (2005) 214-223
9. Peacock C.D., Wang Q., Gesell G.S., Corcoran-Schwartz I.M., Jones E., Kim J., Devereux W.L., Rhodes J.T., Huff C.A., Beachy P.A., Watkins D.N., and Matsui W. Proc. Natl. Acad. Sci. U.S.A. 104 (2007) 4048-4053
10. Ruiz i Altaba A., Mas C., and Stecca B. Trends Cell Biol. 17 (2007) 438-447
11. Stecca B., and Ruiz i Altaba A. J. Neurobiol. 64 (2005) 476-490
12. Sun S., Schiller J.H., Spinola M., and Minna J.D. J. Clin. Invest. 117 (2007) 2740-2750
13. Kinzler K.W., Bigner S.H., Bigner D.D., Trent J.M., Law M.L., O'Brien S.J., Wong A.J., and Vogelstein B. Science 236 (1987) 70-73
14. Kiselyov A.S. Anticancer Agents Med. Chem. 6 (2006) 445-449
15. Kiselyov A.S., Tkachenko S.E., Balakin K.V., and Ivachtchenko A.V. Expert Opin. Ther. Targets 11 (2007) 1087-1101
16. Lauth M., and Toftgård R. Curr. Opin. Investig. Drugs 8 (2007) 457-461
17. Mahindroo N., Punchihewa C., and Fujii N. J. Med. Chem. 52 (2009) 3829-3845
18. Bar E.E., Chaudhry A., Lin A., Fan X., Schreck K., Matsui W., Piccirillo S., Vescovi A.L., DiMeco F., Olivi A., and Eberhart C.G. Stem Cells 10 (2007) 2524-2533
19. Clement V., Sanchez P., de Tribolet N., Radovanovic I., and Ruiz i Altaba A. Curr. Biol. 17 (2007) 165-172
20. For a review see. de Graaf M., Boven E., Scheeren H.W., Haisma H.J., and Pinedo H. Curr. Pharm. Des. 8 (2002) 1391-1403
21. Bosslet K., Czech J., and Hoffmann D. Tumor Target. 1 (1995) 45-50
22. Bosslet K., Straub R., Blumrich M., Czech J., Gerken M., Sperker B., Kroemer H.K., Gesson J.-P., Koch M., and Monneret C. Cancer Res. 58 (1998) 1195-1201
23. Houba P.H., Boven E., Erkenlens C.A., Leenders R.G., Scheeren J.W., Pinedo H.M., and Haisma H.J. Br. J. Cancer 78 (1998) 1600-1606
24. Houba P.H., Boven E., Van der Meulen-Muileman I.H., Leenders R.G., Scheeren J.W., Pinedo H.M., and Haisma H.J. Br. J. Cancer 78 (2001) 550-557
25. Nygren C., von Holst H., Mansson J.-E., and Fredman P. Acta Neurochir 139 (1997) 146-150
26. Papot S., Tranoy I., Tillequin F., Florent J.-C., and Gesson J.-P. Curr. Med. Chem. Anticancer Agents 2 (2002) 155-185
27. Tranoy-Opalinski I., Fernandes A., Thomas M., Gesson J.-P., and Papot S. Anticancer Agents Med. Chem. 8 (2008) 618-637
28. Florent J.-C., Dong X., Gaudel G., Mitaku S., Monneret C., Gesson J.-P., Jacquesy J.-C., Mondon M., Renoux B., Andrianomenjanahary S., Michel S., Koch M., Tillequin F., Gerken M., Czech J., Straub R., and Bosslet K. J. Med. Chem. 41 (1998) 3572-3581
29. Tremblay M.R., Nevalainen M., Nair S.J., Porter J.R., Castro A.C., Behnke M.L., Yu L.-C., Hagel M., White K., Faia K., Grenier L., Campbell M.J., Cushing J., Woodward C.N., Hoyt J., Foley M.A., Read M.A., Sydor J.R., Tong J.K., Palombella V.J., McGovern K., and Adams J. J. Med. Chem. 51 (2008) 6646-6649
30. El Alaoui A., Schmidt F., Monneret C., and Florent J.-C. J. Org. Chem. 71 (2006) 9628-9636
31. The full study concerning this procedure will be published elsewhere.